Loma Linda University Medical Center, CA, USA.
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231165736. doi: 10.1177/23247096231165736.
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid antibodies were detected in the presence of significant thromboses. The patient was subsequently treated for suspected catastrophic antiphospholipid syndrome following COVID-19 infection.
COVID-19 感染已被发现可引发高凝状态,并短暂增加抗磷脂抗体。然而,目前尚不清楚这些短暂变化在多大程度上导致血栓事件和抗磷脂综合征。我们报告了一例 COVID-19 感染后存在明显血栓形成的情况下检测到抗磷脂抗体的病例。随后,该患者被怀疑患有 COVID-19 感染后灾难性抗磷脂综合征而接受治疗。